Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome.
- DOI
- 10.1002/acr2.90153
- Published
- 2026 Oct
- Container
- ACR open rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acr2.90153,
title = {Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome.},
author = {Montes D and Langenfeld HE and Hanson AC and Crowson CS and Patnaik MM and Go RS and Kalantari K and Kusne Y and Lasho T and Mangaonkar AA and Olteanu H and Reichard KK and Sullivan MM and Viswanatha DS and Warrington KJ and Koster MJ},
year = {2026},
journal = {ACR open rheumatology},
doi = {10.1002/acr2.90153},
url = {https://doi.org/10.1002/acr2.90153}
}RIS
TY - JOUR TI - Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome. AU - Montes D AU - Langenfeld HE AU - Hanson AC AU - Crowson CS AU - Patnaik MM AU - Go RS AU - Kalantari K AU - Kusne Y AU - Lasho T AU - Mangaonkar AA AU - Olteanu H AU - Reichard KK AU - Sullivan MM AU - Viswanatha DS AU - Warrington KJ AU - Koster MJ PY - 2026 JO - ACR open rheumatology DO - 10.1002/acr2.90153 UR - https://doi.org/10.1002/acr2.90153 ER -
APA
D, M., HE, L., AC, H., CS, C., MM, P., RS, G., K, K., Y, K., T, L., AA, M., H, O., KK, R., MM, S., DS, V., KJ, W., & MJ, K. (2026). Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome.. ACR open rheumatology. https://doi.org/10.1002/acr2.90153
Source records
- pubmed · retrieved 2026-09-25T18:58:45.028Z